Brazil has ordered 100 million doses of the Pfizer-BioNTech COVID-19 vaccine and another 38 million of Johnson & Johnson’s, the health minister said Monday, seeking to accelerate the hard-hit country’s lagging immunization campaign.
Health Minister Eduardo Pazuello said Brazil had secured a total of 563 million vaccine doses by the end of the year—some single- and some double-dose vaccines—and defended his handling of the pandemic, as rumors swirled that far-right President Jair Bolsonaro was close to firing him amid a surge in new cases and deaths in Brazil.
COVID-19 has been pushing hospitals close to the breaking point across the country of 212 million people, where the death toll now stands at more than 278,000—second only to the United States.
Bolsonaro’s government has faced criticism for failing to secure enough doses of vaccine, forcing local officials to suspend immunization in some areas.
Around 4.6 percent of the population has received at least one dose of vaccine so far.
Currently, the two shots being used in Brazil are the Oxford-AstraZeneca vaccine and Chinese-developed CoronaVac.
Bolsonaro, who has defied expert advice on handling the pandemic at virtually every turn—vowing not to get vaccinated himself and joking vaccines could “turn you into an alligator”—has recently shown signs of trying to overhaul that image.
Pazuello, an army general with no prior medical experience who is Brazil’s third health minister of the pandemic, confirmed the president was “evaluating names” to replace him.
“There will be continuity” with his replacement, he told a news conference.
“We will ensure a proper transition.”
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 AFP
Brazil orders 100 million doses of Pfizer vaccine (2021, March 15)
retrieved 15 March 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022